Innovation1 Biotech Inc. (IVBT)

Market Cap	4.49K -99.2%
Revenue (ttm)	n/a
Net Income	-6.21M
EPS	-0.30
Shares Out	22.47M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,691
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0050
Beta	17.00
RSI	39.87
Earnings Date	Apr 17, 2026

About Innovation1 Biotech

Innovation1 Biotech Inc. focuses on researching, developing, producing, and selling pharmaceutical products. The company offers natural supplements for the treatment of symptoms associated with the flu and long covid under the NutraFlu and Nutravid19 brands; and other supplement and medical nutrition products. It also develops NLC001 that is in Phase II clinical trial for the treatment of long covid and other viral indications. The company is based in New York, New York.

• Industry: Shell Companies
• Sector: Financials
• Founded: 2014
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: IVBT